Skip to main content
. 2022 Dec 23;12(7):8378–8387. doi: 10.1002/cam4.5558

FIGURE 4.

FIGURE 4

ML inhibits H82 xenograft tumor growth. (A) Tumor volume measurement over the course of treatment with: PBS (control), ML, cisplatin, or ML + cisplatin. (B) Tumor volume on day 27 of treatment. **p < 0.01, ****p < 0.0001 for comparison with PBS group.